After thyroid cancer
Conditions
Interventions
Experimental group:Oral Yiyang Pill
Blank Group:Oral Placebo
Sponsors
China-Japan Friendship Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) DTC was diagnosed by pathology after operation and aged less than 65 years; (2) TSH suppression therapy was performed routinely for more than one year after operation; (3) The TSH inhibitory target is below the normal level and belongs to subclinical hyperthyroidism; (4) Conscious symptoms such as panic and chest tightness, but resting heart rate is less than 90 times; (5) TCM syndrome is Qi and Yindeficiency; (6) Patients who have signed informed consent.
Exclusion criteria
Exclusion criteria: (1) Those who had cardiovascular abnormalities and diseases; (2) Patients with severe systemic and psychiatric diseases such as liver and kidney; (3) Anaphylaxis to the components contained in drugs; (4) Found distant metastases; (5) Pregnant and lactating women; (6) Those who are participating in other clinical drug trials; (7) Patients who do not sign the informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 24 hour dynamic electrocardiogram;TSH;FT3;FT4; | — |
Secondary
| Measure | Time frame |
|---|---|
| Liver function;Renal function;Routine blood test;Blood pressure; | — |
Countries
China
Contacts
Public ContactXia Zhongyuan
China-Japan Friendship Hospital
Outcome results
None listed